FinSMEs:

China-based TandemAI, which uses AI to speed up the design and optimization of drug candidates, raises $25M in seed and “pre-Series A” funding  —  TandemAI, a Suzhou, and Shangai, China-based provider of a computational platform to accelerate the design and optimization of drug candidates …





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here